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SUMMARY
Isolates of feline calicivirus (FCV) can be divided into four groups according to plaque size under an agar overlay. All isolates classified as minute plaque, along with certain other isolates, are sensitive to inhibitors present in agar.
Since the first isolation of a feline calicivirus (FCV) (Fastier, I957) it has become obvious that these viruses are ubiquitous among cat populations throughout the world. One factor of particular note in this group is marked inter-strain variation in certain characters: in antigenicity (Povey, I974), pathogenicity (Hoover & Kahn, I973; Povey & Hale, ~974) , and apparently in tissue tropism (Wardley & Povey, I977) . In this communication we report on studies of two markers which reflect genetic variation: plaque size and sensitivity to inhibitors in agar. Differences in plaque size among feline calicivirus isolates has been reported before (Prydie, I973; Kalunda et al. I975) but there has been no previous account of inhibition of FCV plaque formation by agar.
FCV strains were obtained from isolates made here and from other laboratories in Europe and the U.S.A. Plaque assays were performed in 5 cm polystyrene plates containing confluent monolayers of a feline embryo cell line, FEA (Jarrett et al. I973) . The cells were cultured in Eagle's MEM (Glasgow modification) with IO % foetal bovine serum and were maintained at 37 °C in an atmosphere of 5 % CO2 in air. The growth medium was removed and Ioo #1 of virus suspension, initially diluted in MEM, was inoculated into each plate. Virus was adsorbed for 6o rain at 37 °C. The inoculum was then removed and the monolayers were washed in medium before application of the overlay. The agar overlay consisted of o'9 % bacto.agar (DIFCO) in Eagle's MEM with 5 % foetal bovine serum and agarose overlays were identical except for the substitution of bacto-agar with agarose (Miles Laboratories). Plates were maintained at 37 °C for 48 h before fixing and staining with o'5 % crystal violet in IO % formalin. Plaque diameters were measured using a photographic enlarger at x 2 magnification. For each FCV strain the mean plaque diameter was calculated from the measurement of between 50 and Ioo plaques.
Glasgow isolates were obtained from cats attending a veterinary clinic. Mouth swabs were taken into MEM and the medium was divided into two: the first sample was used for initial screening in which FCV isolation was recognized by the production of a characteristic cytopathic effect in FEA monolayers. If positive for FCV, the second sample was examined using an agar overlay as described above. Virus clones were produced by three cycles of growing virus from single plaques in plates containing only one or two plaques. After the third cloning, the virus suspension was dispensed in samples and stored at -7o °C for future stock production. Stocks were made by infecting FEA monolayers and harvesting the culture after 24 h. The suspension was ultrasonicated for 30 s, centrifuged at 2ooo rev/min for I5 min to remove cell debris and the supernatant fluid was stored at -7o °C.
There was wide variation in plaque size under agar between FCV strains. representative plates from the assay of four strains. Plaque sizes of G I , G2 and F I I were found to occur in a normal, or near normal, distribution whereas the frequency distribution for plaques of Gxo was positively skewed, most likely due to an 'infraplaque' effect (Lindenmann & Gifford, I963). These strains produced four distinct populations o f plaque sizes (P < o ' o 0 and represent the four plaque size groups o f F C V (see Table I ). The minute plaque (MP), small plaque (SP) and large plaque (LP) groups are more or less equally represented among the available isolates, but strains belonging to the fourth group, producing 'extra-large' plaques (EP), are u n c o m m o n : we have now examined 34 F C V strains of which only three were classed as EP. Next, agarose overlays were used to determine whether plaque size might be influenced by inhibitory substances present in agar: agarose is the agar fraction free of sulphated polysaccharides which are known to inhibit virus multiplication in several virus-cell systems (Takemoto, 1966) . Agarose forms firmer gels than agar and so, unless inhibition occurs with agar, the plaque size tends to decrease under agarose overlays. However, in certain strains the plaque size was dramatically increased, e.g. G I o (see Fig. I ). If the mean plaque diameter increased by twofold or more, the sensitivity to agar was scored ' + + ' (see Table I ). The sign ' + ' indicates an increase in size, but less than twofold. As can be seen from Table I , all of the M P group were found to be sensitive to agar inhibitors along with some of the SP group. Only one strain of the LP group, strain FPL, was sensitive. To demonstrate further that the inhibition of these strains was associated with the sulphated polysaccharide (polyanion) fraction of agar, a polycation, diethylaminoethyldextran (DEAE-dextran: Sigma Chemical Company), was added to the standard agar overlay and the effect on plaque size was examined. This procedure was first described by Liebhaber & Takemoto 096I) for EMC virus. As expected, strains showing an increased plaque size with agarose produced larger plaques when DEAE-dextran was added to the agar overlay. For example, the plaques of strain GIO, found to be of the MP type with o to IOO/zg DEAE-dextran per ml of overlay, were converted to LP-size plaques with 500 to ~ooo #g/ml. Strain GI produced plaques of equal size with o to Iooo/zg DEAEdextran/ml in the overlay.
We are interested in finding out whether the mechanisms which underlie the differences between FCV isolates which are apparent by the methods employed here, are relevant to other differences, particularly pathogenicity. Kalunda et al. 0975) reported that in neutralization tests using plaque reduction there was no correlation between plaque size and serotype, and Prydie (I973) could find no correlation between plaque size and pathogenicity. However, our results suggest that a more strict classification based on plaque morphology is required before any such comparisons can be made. For example, it has been reported that different preparations of commerical agar may vary in their inhibitory properties (Wallis et al. I962) . A standardized assay method, such as the one detailed here is required. Sub-classification based on sensitivity to agar inhibitors helps to further characterize any new isolate. In addition, new isolates should be plaque cloned: during this study we have encountered two isolates where a mixed plaque type was present on primary isolation (EP/LP mixture and LP/MP mixture), and obviously an erroneous result would be obtained if an attempt was made to describe and then classify such a mixed population in terms of plaque size.
It may be relevant that in a study of another major virus of this genus, vesicular exanthema virus of swine, it was recognized that there was variation in plaque morphology both between and within antigenic types, and that a cloned LPF (large plaque former) was pathogenic whereas a cloned MPF (minute plaque former) was not (McClain et al. Short communications 1958) . Work is now in progress here to examine the pathogenicity of representative strains from each FCV plaque type, and early results indicate a correlation between the MP group and low pathogenicity, and the EP group with a high level of pathogenicity. If this is found to be a general rule it may help to define the basis of variation in pathogenicity among FCV strains.
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